ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmacovigilance Consulting Services Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-4X17862
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmacovigilance Consulting Services Market Research Report 2024
BUY CHAPTERS

Global Pharmacovigilance Consulting Services Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-4X17862
Report
October 2025
Pages:168
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Eurofins Scientific
Accenture Plc
PPD
SGS Ltd
WuXi AppTec
Cognizant
ICON
IQVIA
PAREXEL
United BioSource
Vial
WIPRO LIMITED
PrimeVigilance
TransPerfect
ProPharma
HCLTECH
QbD Group
Quanticate
Veristat
Veeda
Tigermed
Clarivate
Aixial Group
Qinecsa Solutions

Pharmacovigilance Consulting Services Market

The global Pharmacovigilance Consulting Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Preclinical accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Pharmacovigilance Consulting Services leading manufacturers including Eurofins Scientific, Accenture, PPD, SGS, WuXi AppTec, Cognizant, ICON, IQVIA, Parexel, United BioSource, etc., dominate supply; the top five capture approximately % of global revenue, with Eurofins Scientific leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Pharmacovigilance Consulting Services market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Pharmacovigilance Consulting Services Market Report

Report Metric Details
Report Name Pharmacovigilance Consulting Services Market
Segment by Type
  • Writing and Submitting Documents and Reports
  • Security Database System Services and Data Management
  • Signal Detection and Evaluation
  • Training and Consulting
  • Other
Segment by Application
  • Preclinical
  • Clinical Phase
  • Post-launch
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Eurofins Scientific, Accenture, PPD, SGS, WuXi AppTec, Cognizant, ICON, IQVIA, Parexel, United BioSource, Vial, Wipro, PrimeVigilance, Aixial Group, TransPerfect, ProPharma, HCLTech, QbD Group, Quanticate, Qinecsa Solutions, Veristat, Veeda, Tigermed, Clarivate
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Pharmacovigilance Consulting Services study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Pharmacovigilance Consulting Services Market report?

Ans: The main players in the Pharmacovigilance Consulting Services Market are Eurofins Scientific, Accenture, PPD, SGS, WuXi AppTec, Cognizant, ICON, IQVIA, Parexel, United BioSource, Vial, Wipro, PrimeVigilance, Aixial Group, TransPerfect, ProPharma, HCLTech, QbD Group, Quanticate, Qinecsa Solutions, Veristat, Veeda, Tigermed, Clarivate

What are the Application segmentation covered in the Pharmacovigilance Consulting Services Market report?

Ans: The Applications covered in the Pharmacovigilance Consulting Services Market report are Preclinical, Clinical Phase, Post-launch

What are the Type segmentation covered in the Pharmacovigilance Consulting Services Market report?

Ans: The Types covered in the Pharmacovigilance Consulting Services Market report are Writing and Submitting Documents and Reports, Security Database System Services and Data Management, Signal Detection and Evaluation, Training and Consulting, Other

1 Study Coverage
1.1 Introduction to Pharmacovigilance Consulting Services: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Pharmacovigilance Consulting Services Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Writing and Submitting Documents and Reports
1.2.3 Security Database System Services and Data Management
1.2.4 Signal Detection and Evaluation
1.2.5 Training and Consulting
1.2.6 Other
1.3 Market Segmentation by Application
1.3.1 Global Pharmacovigilance Consulting Services Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Preclinical
1.3.3 Clinical Phase
1.3.4 Post-launch
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pharmacovigilance Consulting Services Revenue Estimates and Forecasts 2020-2031
2.2 Global Pharmacovigilance Consulting Services Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Pharmacovigilance Consulting Services Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Pharmacovigilance Consulting Services Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Writing and Submitting Documents and Reports Market Size by Players
3.3.2 Security Database System Services and Data Management Market Size by Players
3.3.3 Signal Detection and Evaluation Market Size by Players
3.3.4 Training and Consulting Market Size by Players
3.3.5 Other Market Size by Players
3.4 Global Pharmacovigilance Consulting Services Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Pharmacovigilance Consulting Services Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Pharmacovigilance Consulting Services Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Pharmacovigilance Consulting Services Market Size by Type (2020-2031)
6.4 North America Pharmacovigilance Consulting Services Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Pharmacovigilance Consulting Services Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Pharmacovigilance Consulting Services Market Size by Type (2020-2031)
7.4 Europe Pharmacovigilance Consulting Services Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Pharmacovigilance Consulting Services Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Pharmacovigilance Consulting Services Market Size by Type (2020-2031)
8.4 Asia-Pacific Pharmacovigilance Consulting Services Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Pharmacovigilance Consulting Services Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Pharmacovigilance Consulting Services Market Size by Type (2020-2031)
9.4 Central and South America Pharmacovigilance Consulting Services Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Pharmacovigilance Consulting Services Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Pharmacovigilance Consulting Services Market Size by Type (2020-2031)
10.4 Middle East and Africa Pharmacovigilance Consulting Services Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Pharmacovigilance Consulting Services Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Eurofins Scientific
11.1.1 Eurofins Scientific Corporation Information
11.1.2 Eurofins Scientific Business Overview
11.1.3 Eurofins Scientific Pharmacovigilance Consulting Services Product Features and Attributes
11.1.4 Eurofins Scientific Pharmacovigilance Consulting Services Revenue and Gross Margin (2020-2025)
11.1.5 Eurofins Scientific Pharmacovigilance Consulting Services Revenue by Product in 2024
11.1.6 Eurofins Scientific Pharmacovigilance Consulting Services Revenue by Application in 2024
11.1.7 Eurofins Scientific Pharmacovigilance Consulting Services Revenue by Geographic Area in 2024
11.1.8 Eurofins Scientific Pharmacovigilance Consulting Services SWOT Analysis
11.1.9 Eurofins Scientific Recent Developments
11.2 Accenture
11.2.1 Accenture Corporation Information
11.2.2 Accenture Business Overview
11.2.3 Accenture Pharmacovigilance Consulting Services Product Features and Attributes
11.2.4 Accenture Pharmacovigilance Consulting Services Revenue and Gross Margin (2020-2025)
11.2.5 Accenture Pharmacovigilance Consulting Services Revenue by Product in 2024
11.2.6 Accenture Pharmacovigilance Consulting Services Revenue by Application in 2024
11.2.7 Accenture Pharmacovigilance Consulting Services Revenue by Geographic Area in 2024
11.2.8 Accenture Pharmacovigilance Consulting Services SWOT Analysis
11.2.9 Accenture Recent Developments
11.3 PPD
11.3.1 PPD Corporation Information
11.3.2 PPD Business Overview
11.3.3 PPD Pharmacovigilance Consulting Services Product Features and Attributes
11.3.4 PPD Pharmacovigilance Consulting Services Revenue and Gross Margin (2020-2025)
11.3.5 PPD Pharmacovigilance Consulting Services Revenue by Product in 2024
11.3.6 PPD Pharmacovigilance Consulting Services Revenue by Application in 2024
11.3.7 PPD Pharmacovigilance Consulting Services Revenue by Geographic Area in 2024
11.3.8 PPD Pharmacovigilance Consulting Services SWOT Analysis
11.3.9 PPD Recent Developments
11.4 SGS
11.4.1 SGS Corporation Information
11.4.2 SGS Business Overview
11.4.3 SGS Pharmacovigilance Consulting Services Product Features and Attributes
11.4.4 SGS Pharmacovigilance Consulting Services Revenue and Gross Margin (2020-2025)
11.4.5 SGS Pharmacovigilance Consulting Services Revenue by Product in 2024
11.4.6 SGS Pharmacovigilance Consulting Services Revenue by Application in 2024
11.4.7 SGS Pharmacovigilance Consulting Services Revenue by Geographic Area in 2024
11.4.8 SGS Pharmacovigilance Consulting Services SWOT Analysis
11.4.9 SGS Recent Developments
11.5 WuXi AppTec
11.5.1 WuXi AppTec Corporation Information
11.5.2 WuXi AppTec Business Overview
11.5.3 WuXi AppTec Pharmacovigilance Consulting Services Product Features and Attributes
11.5.4 WuXi AppTec Pharmacovigilance Consulting Services Revenue and Gross Margin (2020-2025)
11.5.5 WuXi AppTec Pharmacovigilance Consulting Services Revenue by Product in 2024
11.5.6 WuXi AppTec Pharmacovigilance Consulting Services Revenue by Application in 2024
11.5.7 WuXi AppTec Pharmacovigilance Consulting Services Revenue by Geographic Area in 2024
11.5.8 WuXi AppTec Pharmacovigilance Consulting Services SWOT Analysis
11.5.9 WuXi AppTec Recent Developments
11.6 Cognizant
11.6.1 Cognizant Corporation Information
11.6.2 Cognizant Business Overview
11.6.3 Cognizant Pharmacovigilance Consulting Services Product Features and Attributes
11.6.4 Cognizant Pharmacovigilance Consulting Services Revenue and Gross Margin (2020-2025)
11.6.5 Cognizant Recent Developments
11.7 ICON
11.7.1 ICON Corporation Information
11.7.2 ICON Business Overview
11.7.3 ICON Pharmacovigilance Consulting Services Product Features and Attributes
11.7.4 ICON Pharmacovigilance Consulting Services Revenue and Gross Margin (2020-2025)
11.7.5 ICON Recent Developments
11.8 IQVIA
11.8.1 IQVIA Corporation Information
11.8.2 IQVIA Business Overview
11.8.3 IQVIA Pharmacovigilance Consulting Services Product Features and Attributes
11.8.4 IQVIA Pharmacovigilance Consulting Services Revenue and Gross Margin (2020-2025)
11.8.5 IQVIA Recent Developments
11.9 Parexel
11.9.1 Parexel Corporation Information
11.9.2 Parexel Business Overview
11.9.3 Parexel Pharmacovigilance Consulting Services Product Features and Attributes
11.9.4 Parexel Pharmacovigilance Consulting Services Revenue and Gross Margin (2020-2025)
11.9.5 Parexel Recent Developments
11.10 United BioSource
11.10.1 United BioSource Corporation Information
11.10.2 United BioSource Business Overview
11.10.3 United BioSource Pharmacovigilance Consulting Services Product Features and Attributes
11.10.4 United BioSource Pharmacovigilance Consulting Services Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Vial
11.11.1 Vial Corporation Information
11.11.2 Vial Business Overview
11.11.3 Vial Pharmacovigilance Consulting Services Product Features and Attributes
11.11.4 Vial Pharmacovigilance Consulting Services Revenue and Gross Margin (2020-2025)
11.11.5 Vial Recent Developments
11.12 Wipro
11.12.1 Wipro Corporation Information
11.12.2 Wipro Business Overview
11.12.3 Wipro Pharmacovigilance Consulting Services Product Features and Attributes
11.12.4 Wipro Pharmacovigilance Consulting Services Revenue and Gross Margin (2020-2025)
11.12.5 Wipro Recent Developments
11.13 PrimeVigilance
11.13.1 PrimeVigilance Corporation Information
11.13.2 PrimeVigilance Business Overview
11.13.3 PrimeVigilance Pharmacovigilance Consulting Services Product Features and Attributes
11.13.4 PrimeVigilance Pharmacovigilance Consulting Services Revenue and Gross Margin (2020-2025)
11.13.5 PrimeVigilance Recent Developments
11.14 Aixial Group
11.14.1 Aixial Group Corporation Information
11.14.2 Aixial Group Business Overview
11.14.3 Aixial Group Pharmacovigilance Consulting Services Product Features and Attributes
11.14.4 Aixial Group Pharmacovigilance Consulting Services Revenue and Gross Margin (2020-2025)
11.14.5 Aixial Group Recent Developments
11.15 TransPerfect
11.15.1 TransPerfect Corporation Information
11.15.2 TransPerfect Business Overview
11.15.3 TransPerfect Pharmacovigilance Consulting Services Product Features and Attributes
11.15.4 TransPerfect Pharmacovigilance Consulting Services Revenue and Gross Margin (2020-2025)
11.15.5 TransPerfect Recent Developments
11.16 ProPharma
11.16.1 ProPharma Corporation Information
11.16.2 ProPharma Business Overview
11.16.3 ProPharma Pharmacovigilance Consulting Services Product Features and Attributes
11.16.4 ProPharma Pharmacovigilance Consulting Services Revenue and Gross Margin (2020-2025)
11.16.5 ProPharma Recent Developments
11.17 HCLTech
11.17.1 HCLTech Corporation Information
11.17.2 HCLTech Business Overview
11.17.3 HCLTech Pharmacovigilance Consulting Services Product Features and Attributes
11.17.4 HCLTech Pharmacovigilance Consulting Services Revenue and Gross Margin (2020-2025)
11.17.5 HCLTech Recent Developments
11.18 QbD Group
11.18.1 QbD Group Corporation Information
11.18.2 QbD Group Business Overview
11.18.3 QbD Group Pharmacovigilance Consulting Services Product Features and Attributes
11.18.4 QbD Group Pharmacovigilance Consulting Services Revenue and Gross Margin (2020-2025)
11.18.5 QbD Group Recent Developments
11.19 Quanticate
11.19.1 Quanticate Corporation Information
11.19.2 Quanticate Business Overview
11.19.3 Quanticate Pharmacovigilance Consulting Services Product Features and Attributes
11.19.4 Quanticate Pharmacovigilance Consulting Services Revenue and Gross Margin (2020-2025)
11.19.5 Quanticate Recent Developments
11.20 Qinecsa Solutions
11.20.1 Qinecsa Solutions Corporation Information
11.20.2 Qinecsa Solutions Business Overview
11.20.3 Qinecsa Solutions Pharmacovigilance Consulting Services Product Features and Attributes
11.20.4 Qinecsa Solutions Pharmacovigilance Consulting Services Revenue and Gross Margin (2020-2025)
11.20.5 Qinecsa Solutions Recent Developments
11.21 Veristat
11.21.1 Veristat Corporation Information
11.21.2 Veristat Business Overview
11.21.3 Veristat Pharmacovigilance Consulting Services Product Features and Attributes
11.21.4 Veristat Pharmacovigilance Consulting Services Revenue and Gross Margin (2020-2025)
11.21.5 Veristat Recent Developments
11.22 Veeda
11.22.1 Veeda Corporation Information
11.22.2 Veeda Business Overview
11.22.3 Veeda Pharmacovigilance Consulting Services Product Features and Attributes
11.22.4 Veeda Pharmacovigilance Consulting Services Revenue and Gross Margin (2020-2025)
11.22.5 Veeda Recent Developments
11.23 Tigermed
11.23.1 Tigermed Corporation Information
11.23.2 Tigermed Business Overview
11.23.3 Tigermed Pharmacovigilance Consulting Services Product Features and Attributes
11.23.4 Tigermed Pharmacovigilance Consulting Services Revenue and Gross Margin (2020-2025)
11.23.5 Tigermed Recent Developments
11.24 Clarivate
11.24.1 Clarivate Corporation Information
11.24.2 Clarivate Business Overview
11.24.3 Clarivate Pharmacovigilance Consulting Services Product Features and Attributes
11.24.4 Clarivate Pharmacovigilance Consulting Services Revenue and Gross Margin (2020-2025)
11.24.5 Clarivate Recent Developments
12 Pharmacovigilance Consulting ServicesIndustry Chain Analysis
12.1 Pharmacovigilance Consulting Services Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Pharmacovigilance Consulting Services Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Pharmacovigilance Consulting Services Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Eurofins Scientific
Accenture Plc
PPD
SGS Ltd
WuXi AppTec
Cognizant
ICON
IQVIA
PAREXEL
United BioSource
Vial
WIPRO LIMITED
PrimeVigilance
TransPerfect
ProPharma
HCLTECH
QbD Group
Quanticate
Veristat
Veeda
Tigermed
Clarivate
Aixial Group
Qinecsa Solutions
List of Tables
 Table 1. Global Pharmacovigilance Consulting Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Pharmacovigilance Consulting Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Pharmacovigilance Consulting Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Pharmacovigilance Consulting Services Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Pharmacovigilance Consulting Services Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Pharmacovigilance Consulting Services Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Pharmacovigilance Consulting Services Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Pharmacovigilance Consulting Services by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacovigilance Consulting Services as of 2024)
 Table 11. Global Pharmacovigilance Consulting Services Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Pharmacovigilance Consulting Services Companies Headquarters
 Table 13. Global Pharmacovigilance Consulting Services Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Pharmacovigilance Consulting Services Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Pharmacovigilance Consulting Services Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Pharmacovigilance Consulting Services Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Pharmacovigilance Consulting Services Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Pharmacovigilance Consulting Services High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Pharmacovigilance Consulting Services Growth Accelerators and Market Barriers
 Table 25. North America Pharmacovigilance Consulting Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Pharmacovigilance Consulting Services Growth Accelerators and Market Barriers
 Table 27. Europe Pharmacovigilance Consulting Services Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Pharmacovigilance Consulting Services Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Pharmacovigilance Consulting Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Pharmacovigilance Consulting Services Investment Opportunities and Key Challenges
 Table 31. Central and South America Pharmacovigilance Consulting Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Pharmacovigilance Consulting Services Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Pharmacovigilance Consulting Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Eurofins Scientific Corporation Information
 Table 35. Eurofins Scientific Description and Major Businesses
 Table 36. Eurofins Scientific Product Features and Attributes
 Table 37. Eurofins Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Eurofins Scientific Revenue Proportion by Product in 2024
 Table 39. Eurofins Scientific Revenue Proportion by Application in 2024
 Table 40. Eurofins Scientific Revenue Proportion by Geographic Area in 2024
 Table 41. Eurofins Scientific Pharmacovigilance Consulting Services SWOT Analysis
 Table 42. Eurofins Scientific Recent Developments
 Table 43. Accenture Corporation Information
 Table 44. Accenture Description and Major Businesses
 Table 45. Accenture Product Features and Attributes
 Table 46. Accenture Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Accenture Revenue Proportion by Product in 2024
 Table 48. Accenture Revenue Proportion by Application in 2024
 Table 49. Accenture Revenue Proportion by Geographic Area in 2024
 Table 50. Accenture Pharmacovigilance Consulting Services SWOT Analysis
 Table 51. Accenture Recent Developments
 Table 52. PPD Corporation Information
 Table 53. PPD Description and Major Businesses
 Table 54. PPD Product Features and Attributes
 Table 55. PPD Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. PPD Revenue Proportion by Product in 2024
 Table 57. PPD Revenue Proportion by Application in 2024
 Table 58. PPD Revenue Proportion by Geographic Area in 2024
 Table 59. PPD Pharmacovigilance Consulting Services SWOT Analysis
 Table 60. PPD Recent Developments
 Table 61. SGS Corporation Information
 Table 62. SGS Description and Major Businesses
 Table 63. SGS Product Features and Attributes
 Table 64. SGS Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. SGS Revenue Proportion by Product in 2024
 Table 66. SGS Revenue Proportion by Application in 2024
 Table 67. SGS Revenue Proportion by Geographic Area in 2024
 Table 68. SGS Pharmacovigilance Consulting Services SWOT Analysis
 Table 69. SGS Recent Developments
 Table 70. WuXi AppTec Corporation Information
 Table 71. WuXi AppTec Description and Major Businesses
 Table 72. WuXi AppTec Product Features and Attributes
 Table 73. WuXi AppTec Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. WuXi AppTec Revenue Proportion by Product in 2024
 Table 75. WuXi AppTec Revenue Proportion by Application in 2024
 Table 76. WuXi AppTec Revenue Proportion by Geographic Area in 2024
 Table 77. WuXi AppTec Pharmacovigilance Consulting Services SWOT Analysis
 Table 78. WuXi AppTec Recent Developments
 Table 79. Cognizant Corporation Information
 Table 80. Cognizant Description and Major Businesses
 Table 81. Cognizant Product Features and Attributes
 Table 82. Cognizant Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Cognizant Recent Developments
 Table 84. ICON Corporation Information
 Table 85. ICON Description and Major Businesses
 Table 86. ICON Product Features and Attributes
 Table 87. ICON Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. ICON Recent Developments
 Table 89. IQVIA Corporation Information
 Table 90. IQVIA Description and Major Businesses
 Table 91. IQVIA Product Features and Attributes
 Table 92. IQVIA Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. IQVIA Recent Developments
 Table 94. Parexel Corporation Information
 Table 95. Parexel Description and Major Businesses
 Table 96. Parexel Product Features and Attributes
 Table 97. Parexel Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Parexel Recent Developments
 Table 99. United BioSource Corporation Information
 Table 100. United BioSource Description and Major Businesses
 Table 101. United BioSource Product Features and Attributes
 Table 102. United BioSource Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. United BioSource Recent Developments
 Table 104. Vial Corporation Information
 Table 105. Vial Description and Major Businesses
 Table 106. Vial Product Features and Attributes
 Table 107. Vial Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Vial Recent Developments
 Table 109. Wipro Corporation Information
 Table 110. Wipro Description and Major Businesses
 Table 111. Wipro Product Features and Attributes
 Table 112. Wipro Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Wipro Recent Developments
 Table 114. PrimeVigilance Corporation Information
 Table 115. PrimeVigilance Description and Major Businesses
 Table 116. PrimeVigilance Product Features and Attributes
 Table 117. PrimeVigilance Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. PrimeVigilance Recent Developments
 Table 119. Aixial Group Corporation Information
 Table 120. Aixial Group Description and Major Businesses
 Table 121. Aixial Group Product Features and Attributes
 Table 122. Aixial Group Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. Aixial Group Recent Developments
 Table 124. TransPerfect Corporation Information
 Table 125. TransPerfect Description and Major Businesses
 Table 126. TransPerfect Product Features and Attributes
 Table 127. TransPerfect Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. TransPerfect Recent Developments
 Table 129. ProPharma Corporation Information
 Table 130. ProPharma Description and Major Businesses
 Table 131. ProPharma Product Features and Attributes
 Table 132. ProPharma Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 133. ProPharma Recent Developments
 Table 134. HCLTech Corporation Information
 Table 135. HCLTech Description and Major Businesses
 Table 136. HCLTech Product Features and Attributes
 Table 137. HCLTech Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 138. HCLTech Recent Developments
 Table 139. QbD Group Corporation Information
 Table 140. QbD Group Description and Major Businesses
 Table 141. QbD Group Product Features and Attributes
 Table 142. QbD Group Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 143. QbD Group Recent Developments
 Table 144. Quanticate Corporation Information
 Table 145. Quanticate Description and Major Businesses
 Table 146. Quanticate Product Features and Attributes
 Table 147. Quanticate Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 148. Quanticate Recent Developments
 Table 149. Qinecsa Solutions Corporation Information
 Table 150. Qinecsa Solutions Description and Major Businesses
 Table 151. Qinecsa Solutions Product Features and Attributes
 Table 152. Qinecsa Solutions Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 153. Qinecsa Solutions Recent Developments
 Table 154. Veristat Corporation Information
 Table 155. Veristat Description and Major Businesses
 Table 156. Veristat Product Features and Attributes
 Table 157. Veristat Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 158. Veristat Recent Developments
 Table 159. Veeda Corporation Information
 Table 160. Veeda Description and Major Businesses
 Table 161. Veeda Product Features and Attributes
 Table 162. Veeda Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 163. Veeda Recent Developments
 Table 164. Tigermed Corporation Information
 Table 165. Tigermed Description and Major Businesses
 Table 166. Tigermed Product Features and Attributes
 Table 167. Tigermed Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 168. Tigermed Recent Developments
 Table 169. Clarivate Corporation Information
 Table 170. Clarivate Description and Major Businesses
 Table 171. Clarivate Product Features and Attributes
 Table 172. Clarivate Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 173. Clarivate Recent Developments
 Table 174. Raw Materials Key Suppliers
 Table 175. Distributors List
 Table 176. Market Trends and Market Evolution
 Table 177. Market Drivers and Opportunities
 Table 178. Market Challenges, Risks, and Restraints
 Table 179. Research Programs/Design for This Report
 Table 180. Key Data Information from Secondary Sources
 Table 181. Key Data Information from Primary Sources


List of Figures
 Figure 1. Pharmacovigilance Consulting Services Product Picture
 Figure 2. Global Pharmacovigilance Consulting Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Writing and Submitting Documents and Reports Product Picture
 Figure 4. Security Database System Services and Data Management Product Picture
 Figure 5. Signal Detection and Evaluation Product Picture
 Figure 6. Training and Consulting Product Picture
 Figure 7. Other Product Picture
 Figure 8. Global Pharmacovigilance Consulting Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 9. Preclinical
 Figure 10. Clinical Phase
 Figure 11. Post-launch
 Figure 12. Pharmacovigilance Consulting Services Report Years Considered
 Figure 13. Global Pharmacovigilance Consulting Services Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Pharmacovigilance Consulting Services Revenue (2020-2031) & (US$ Million)
 Figure 15. Global Pharmacovigilance Consulting Services Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 16. Global Pharmacovigilance Consulting Services Revenue Market Share by Region (2020-2031)
 Figure 17. Global Pharmacovigilance Consulting Services Revenue Market Share Ranking (2024)
 Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 19. Writing and Submitting Documents and Reports Revenue Market Share by Player in 2024
 Figure 20. Security Database System Services and Data Management Revenue Market Share by Player in 2024
 Figure 21. Signal Detection and Evaluation Revenue Market Share by Player in 2024
 Figure 22. Training and Consulting Revenue Market Share by Player in 2024
 Figure 23. Other Revenue Market Share by Player in 2024
 Figure 24. Global Pharmacovigilance Consulting Services Revenue Market Share by Type (2020-2031)
 Figure 25. Global Pharmacovigilance Consulting Services Revenue Market Share by Application (2020-2031)
 Figure 26. North America Pharmacovigilance Consulting Services Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. North America Top 5 Players Pharmacovigilance Consulting Services Revenue (US$ Million) in 2024
 Figure 28. North America Pharmacovigilance Consulting Services Revenue (US$ Million) by Type (2020 - 2031)
 Figure 29. North America Pharmacovigilance Consulting Services Revenue (US$ Million) by Application (2020-2031)
 Figure 30. US Pharmacovigilance Consulting Services Revenue (2020-2031) & (US$ Million)
 Figure 31. Canada Pharmacovigilance Consulting Services Revenue (2020-2031) & (US$ Million)
 Figure 32. Mexico Pharmacovigilance Consulting Services Revenue (2020-2031) & (US$ Million)
 Figure 33. Europe Pharmacovigilance Consulting Services Revenue YoY (2020-2031) & (US$ Million)
 Figure 34. Europe Top 5 Players Pharmacovigilance Consulting Services Revenue (US$ Million) in 2024
 Figure 35. Europe Pharmacovigilance Consulting Services Revenue (US$ Million) by Type (2020-2031)
 Figure 36. Europe Pharmacovigilance Consulting Services Revenue (US$ Million) by Application (2020-2031)
 Figure 37. Germany Pharmacovigilance Consulting Services Revenue (2020-2031) & (US$ Million)
 Figure 38. France Pharmacovigilance Consulting Services Revenue (2020-2031) & (US$ Million)
 Figure 39. U.K. Pharmacovigilance Consulting Services Revenue (2020-2031) & (US$ Million)
 Figure 40. Italy Pharmacovigilance Consulting Services Revenue (2020-2031) & (US$ Million)
 Figure 41. Russia Pharmacovigilance Consulting Services Revenue (2020-2031) & (US$ Million)
 Figure 42. Asia-Pacific Pharmacovigilance Consulting Services Revenue YoY (2020-2031) & (US$ Million)
 Figure 43. Asia-Pacific Top 8 Players Pharmacovigilance Consulting Services Revenue (US$ Million) in 2024
 Figure 44. Asia-Pacific Pharmacovigilance Consulting Services Revenue (US$ Million) by Type (2020-2031)
 Figure 45. Asia-Pacific Pharmacovigilance Consulting Services Revenue (US$ Million) by Application (2020-2031)
 Figure 46. Indonesia Pharmacovigilance Consulting Services Revenue (2020-2031) & (US$ Million)
 Figure 47. Japan Pharmacovigilance Consulting Services Revenue (2020-2031) & (US$ Million)
 Figure 48. South Korea Pharmacovigilance Consulting Services Revenue (2020-2031) & (US$ Million)
 Figure 49. Australia Pharmacovigilance Consulting Services Revenue (2020-2031) & (US$ Million)
 Figure 50. India Pharmacovigilance Consulting Services Revenue (2020-2031) & (US$ Million)
 Figure 51. Indonesia Pharmacovigilance Consulting Services Revenue (2020-2031) & (US$ Million)
 Figure 52. Vietnam Pharmacovigilance Consulting Services Revenue (2020-2031) & (US$ Million)
 Figure 53. Malaysia Pharmacovigilance Consulting Services Revenue (2020-2031) & (US$ Million)
 Figure 54. Philippines Pharmacovigilance Consulting Services Revenue (2020-2031) & (US$ Million)
 Figure 55. Singapore Pharmacovigilance Consulting Services Revenue (2020-2031) & (US$ Million)
 Figure 56. Central and South America Pharmacovigilance Consulting Services Revenue YoY (2020-2031) & (US$ Million)
 Figure 57. Central and South America Top 5 Players Pharmacovigilance Consulting Services Revenue (US$ Million) in 2024
 Figure 58. Central and South America Pharmacovigilance Consulting Services Revenue (US$ Million) by Type (2020-2031)
 Figure 59. Central and South America Pharmacovigilance Consulting Services Revenue (US$ Million) by Application (2020-2031)
 Figure 60. Brazil Pharmacovigilance Consulting Services Revenue (2020-2025) & (US$ Million)
 Figure 61. Argentina Pharmacovigilance Consulting Services Revenue (2020-2025) & (US$ Million)
 Figure 62. Middle East and Africa Pharmacovigilance Consulting Services Revenue YoY (2020-2031) & (US$ Million)
 Figure 63. Middle East and Africa Top 5 Players Pharmacovigilance Consulting Services Revenue (US$ Million) in 2024
 Figure 64. South America Pharmacovigilance Consulting Services Revenue (US$ Million) by Type (2020-2031)
 Figure 65. Middle East and Africa Pharmacovigilance Consulting Services Revenue (US$ Million) by Application (2020-2031)
 Figure 66. GCC Countries Pharmacovigilance Consulting Services Revenue (2020-2025) & (US$ Million)
 Figure 67. Israel Pharmacovigilance Consulting Services Revenue (2020-2025) & (US$ Million)
 Figure 68. Egypt Pharmacovigilance Consulting Services Revenue (2020-2025) & (US$ Million)
 Figure 69. South Africa Pharmacovigilance Consulting Services Revenue (2020-2025) & (US$ Million)
 Figure 70. Pharmacovigilance Consulting Services Industry Chain Mapping
 Figure 71. Channels of Distribution (Direct Vs Distribution)
 Figure 72. Bottom-up and Top-down Approaches for This Report
 Figure 73. Data Triangulation
 Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions